-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Friday, Lisata Therapeutics To Be Taken Private By Kuva Labs In A Deal Offering Stockholders $5.00 Per Share Plus A $1.00 Contingent Value Right Per Share

Benzinga·03/09/2026 06:42:53
Listen to the news
  • Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per share
  • Board of directors unanimously approved the transaction and recommends that stockholders tender their shares
  • Transaction expected to close in the second quarter of 2026